GleamWall
中文EN

TWST Twist Bioscience Corp

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1581280 · Fiscal year ends 09/30

Financial factors as of 2026-09-30 (2026Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY22.0%
TTM net income YoY-67.6%
TTM EPS YoY-60.0%
Revenue 3-yr CAGR23.3%
Net income 3-yr CAGR—

Margins

Gross margin52.4%
Operating margin-30.4%
Net margin-28.3%
FCF margin-19.4%
EBITDA margin-24.7%

Returns

ROE-19.1%
ROA-14.8%
ROIC (approx.)-34.2%
Asset turnover0.52x

Leverage & solvency

Liabilities / assets20.8%
Debt / equity0.00x
Current ratio5.86x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.32x
Accruals ratio-10.1%
Payout ratio—
Capex / revenue10.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-09-30FY20252025-09-30
Income statement
Revenue$459.43M$376.57M
Cost of revenue$218.63M$185.57M
Gross profit$240.80M$191.00M
R&D expense$71.84M$80.28M
SG&A expense$301.21M$246.98M
Operating income-$139.46M-$136.26M
Pretax income-$129.80M-$76.95M
Income tax$406,000$719,000
Net income-$130.20M-$77.67M
EBITDA-$112.97M-$111.41M
EPS (basic)-2.08-1.30
EPS (diluted)-2.08-1.30
Weighted avg. shares (diluted)62.62M59.81M
Balance sheet
Cash & equivalents$533.99M$183.05M
Short-term investments$47.91M$49.38M
Receivables$70.19M$57.02M
Inventory$46.41M$28.31M
Current assets$737.22M$332.97M
PP&E, net$122.32M$102.28M
Goodwill$82.19M$82.19M
Intangibles$34.16M$13.43M
Total assets$1.12B$641.86M
Current liabilities$125.81M$91.41M
Total liabilities$233.79M$168.90M
Shareholders' equity$888.02M$472.96M
Shares outstanding67.81M60.63M
Cash flow statement
Operating cash flow-$41.43M-$47.63M
Capital expenditure$47.58M$28.00M
Free cash flow-$89.01M-$75.63M
Investing cash flow-$53.09M-$24.76M
Financing cash flow$446.68M$28.54M
Depreciation & amortization$26.48M$24.85M
Stock-based compensation$69.86M$64.46M

Free plan shows the latest 2 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.